Return to homepagePandemic Pact

to evaluate the safety and immunogenicity of a full or fractional booster (3rd) dose of a COVID-19 mRNA vaccine in study participants previously vaccinated with either 2 fractional doses or 2 full doses of COVID-19 mRNA vaccines

Grant number: INV-041946

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2022

  • Known Financial Commitments (USD)

    $300,000

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    Netherlands

  • Lead Research Institution

    Leiden University Medical Center

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A